Capron Max Liquid
NDC Package 29978-123-16
Package Information
Capron Max (dextromethorphan hbr and pyrilamine maleate) liquids is do not exceed recommended dosage.Adults and children 12 years of age and over:2 teaspoonfuls every 6-8 hours, not to exceed 8 teaspoonfuls in 24 hours, or as directed by a doctorChildren 6 to under 12 years of age:1 teaspoonfuls every 6-8 hours, not to exceed 4 teaspoonfuls in 24 hours, or as directed by a doctorChildren under 6 years of ageConsult a doctor. This formulation utilizes a liquid delivery system. Marketed by Capital Pharmaceutical, Llc, this product is identified by NDC 29978-123 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 2716698 - dextromethorphan HBr 15 MG / pyrilamine maleate 15 MG in 5 mL Oral Solution
- RxCUI: 2716698 - dextromethorphan hydrobromide 3 MG/ML / pyrilamine maleate 3 MG/ML Oral Solution
- RxCUI: 2716698 - dextromethorphan HBr 15 MG / pyrilamine maleate 15 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 29978 - Capital Pharmaceutical, Llc
- 29978-123 - Capron Max
- 29978-123-16 - 1 BOTTLE in 1 BOX / 473 mL in 1 BOTTLE
- 29978-123 - Capron Max
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 29978-123-16 identifies a specific commercial package of 1 bottle in 1 box / 473 ml in 1 bottle of Capron Max, a human over the counter drug labeled by Capital Pharmaceutical, Llc. This liquid is formulated for oral use and contains dextromethorphan hydrobromide; pyrilamine maleate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Capital Pharmaceutical, Llc on June 11, 2025. The current certification is valid through December 31, 2026.
How is this Capital Pharmaceutical, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 29978012316. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.